Literature DB >> 7076373

The social consequences of free trade in health care: a public health response to orthodox economics.

M I Roemer, J E Roemer.   

Abstract

In recent years, difficulties in U.S. health services have been ascribed to excessive government intervention and regulation; high costs and other problems would be solved, it is argued, by "return to the free market and competition." Examination of the past operations of free trade and competition in health care, however, shows that in this market not one of at least five conditions necessary for effective competition exists. Numerous adjustments made by social reflect strikingly the problems caused by these market deficiencies (such as seriously inadequate information or the presence of social "externalities"). Furthermore, even these adjustments-such as medical ethics or health insurance-have generated serious secondary problems. Many types of waste and social inequity also persist, in spite of all the attempts to compensate for market failure. In effect, the so-called free market in health care has survived only because of the extensive regulations and other actions taken to patch it up. Abandoning these adjustments would further aggravate current problems. Only replacement of free trade by systematic social planning could hope to achieve a health care system that allocates resources and distributes services both efficiently and equitably.

Mesh:

Year:  1982        PMID: 7076373     DOI: 10.2190/1EY0-GNUG-7HT1-WLB1

Source DB:  PubMed          Journal:  Int J Health Serv        ISSN: 0020-7314            Impact factor:   1.663


  3 in total

1.  Allocation of health care resources: a challenge for the medical profession.

Authors:  D Naylor; A L Linton
Journal:  CMAJ       Date:  1986-02-15       Impact factor: 8.262

2.  What drives the system?

Authors:  C Rosenberg
Journal:  Bull N Y Acad Med       Date:  1987 Jan-Feb

3.  I.S. Falk, the Committee on the Costs of Medical Care, and the Drive for National Health Insurance.

Authors:  M I Roemer
Journal:  Am J Public Health       Date:  1985-08       Impact factor: 9.308

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.